POMALYST® w/DECADRON® - for Myeloma
POMALYST® (Pomalidomide) with DECADRON® (Dexamethasone) for Myeloma
N/A
N/A
The dose of DECADRON® may be reduced to 20mg per day for patients greater than 75 years of age. Monitor blood sugars. Consider prophylactic anti-thrombotic measures as there may be a risk for DVT and pulmonary embolism. Treatment is given until disease progression.
Drug Mode Given Standard Dose Days to Be Given Frequency Solution Volume Duration
POMALYST® (Pomalidomide) PO 4 mg D1 thru D21 q28 N/A N/A N/A
DECADRON® (Dexamethasone) PO 40 mg D1,8,15 and 22 q28 N/A N/A N/A